𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of murine colon adenocarcinomas and Lewis lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil

✍ Scribed by T. Tsuruo; H. Iida; K. Naganuma; S. Tsukagoshi; Y. Sakurai

Book ID
112285959
Publisher
Springer
Year
1980
Tongue
English
Weight
409 KB
Volume
4
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Selective inhibition of spontaneous pulm
Selective inhibition of spontaneous pulmonary metastasis of lewis lung carcinoma by 5β€²-deoxy-5-fluorouridine
✍ Tohru Ishikawa; Masako Ura; Taeko Yamamoto; Yutaka Tanaka; Hideo Ishitsuka πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 754 KB

5'-deoxy-5-fluorouridine (5'-FUdR) is a cytostatic that is biotransformed to 5-fluorouracil(5-FUra) by pyrimidine nucleoside phosphorylase (PyNPase), the expression of which is up-regulated by tumor necrosis factor QL (TNFa), interleukin-I a (ILla) and interferon 'y (IFNy). In Lewis lung carcinoma (

5-fluorouracil metabolite patterns in vi
5-fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy
✍ Yvonne J. L. Kamm; Arend Heerschap; Gert Rosenbusch; Ivonne M. C. M. Rietjens; J πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 548 KB

## Abstract High‐resolution ^19^F NMR spectroscopy at 9.4 T was used to study the difference in the metabolite pattern of 5‐fluorouracil (5‐FU) between viable and necrotic tissues of C38 murine colon tumors grown in C57BI/6 mice. Studies were performed on perchloric acid extracts of these tumor fra

Curcumin enhances the effects of 5-fluor
Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R
✍ Bhaumik B. Patel; Radha Sengupta; Sadia Qazi; Hetal Vachhani; Yingjie Yu; Arun K πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 297 KB πŸ‘ 1 views

## Abstract Curcumin (diferuloylmethane), which has been shown to inhibit growth of transformed cells, has no discernible toxicity and achieves high levels in colonic mucosa. 5‐fluorouracil (5‐FU) or 5‐FU plus oxaliplatin (FOLFOX) remains the backbone of colorectal cancer chemotherapeutics, but wit